Key Takeaways Hims & Hers saw Q3 2025 revenue growth driven by higher subscribers and online revenue per subscriber.HIMS expanded into Canada via Livewell acquisition and launched the Hers platform in the U.K.Hims & Hers faces pressure from weak margins, reporting controls and integration of recent acquisitions.Hims & Hers Health, Inc.’s (HIMS) investors have been experiencing some short-term losses lately. The San Francisco, CA-based health and wellness platform’s stock has lost 39.2% compared with the ind ...

Rocket Doctor AI has completed the acquisition of Alea Health, strengthening its AI-powered digital health platform and accelerating the delivery of physician-led care.The acquisition supports Rocket Doctor AI’s mission to improve access to high-quality healthcare, particularly for underserved and remote communities across Canada and the United States.This milestone reflects the Company’s continued execution on its growth strategy, integrating complementary technology to enhance clinical efficiency, care ...

Core Insights - Profusa, Inc. has announced a collaboration with Dr. Theodosios Bisdas, a prominent vascular surgeon, to integrate its Lumee™ Oxygen tissue monitoring technology into clinical practice in Greece [1][4] - Dr. Bisdas has extensive experience in endovascular techniques and will conduct clinical studies to explore additional vascular applications of the Lumee platform [2][3] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [5] - The company aims to provide affordable, long-lasting biosensors that deliver actionable medical-grade data for both personal and clinical use [5] Collaboration Details - Dr. Bisdas will utilize Lumee Oxygen tissue monitoring in his practice and continue clinical evaluations for unmet needs in vascular applications [2][4] - The partnership is expected to expand Profusa's network of vascular surgeons and explore future clinical partnerships [4]

Group 1: Company Highlights - Above Food Ingredients Inc. Warrants (OTC:ABVEW) leads the market with an 81.74% increase, reaching $0.69, focusing on disruptive agriculture and international operations in sustainable food [1][7] - SMX (NASDAQ:SMX) follows with a 74.64% rise to $33.67, known for its brand protection and authentication technology, benefiting from innovative anti-counterfeit solutions and a strong financial outlook for 2026 [2][7] - Bristol-Myers Squibb Company Ce (CELG-RI) saw a 71.53% increase to $0.11, driven by advancements in small molecules and biologics, emphasizing drug manufacturing and healthcare treatments [3] - EUDA Health Holdings Limited (EUDAW) experienced a 67.29% rise to $0.12, focusing on virtual consults for non-emergency medical issues, gaining traction in the digital health sector [4] - Momentus Inc. (NASDAQ:MNTS) saw a 61.75% increase to $15.9, specializing in space transportation and in-orbit servicing, supported by industry developments and a recent $5 million private placement [5][7] Group 2: Industry Trends - The market is witnessing dynamic movements with sectors like sustainable food and space exploration capturing investor interest, highlighting the importance of unique industry positions and strategic developments [6]

Unaudited update reflects revenue growth, positive operating income, removal of convertible debt, and improved cash flow profile entering 2026. Company reports $1.99 million in revenue for the nine months ended September 30, 2025, up 32% YoY, eliminates convertible debt, and ends the year with approximately $630,000 in cash. West Palm Beach, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) -- QHSLab Inc. (the “Company”) (OTCQB: USAQ), a digital health infrastructure company focused on supporting primary care practices, t ...

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly†, "the company†), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced plans to release its Beam Steering API for advanced third-party AI application and technology development within the company's Butterfly Gardenâ"¢ and Ultrasound-on-Chipâ"¢ co-development programs. The new API release, expected in the first half of 2026, wi ...

BEIJING, Jan. 5, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today announced the execution of initial computing power-related commercial contracts. Through its subsidiaries, the Company signed multiple sales contracts and framework agreements with an aggregate contract value of approximately ...

Core Viewpoint - Equasens has acquired an 80% controlling interest in Erevo, a leading e-learning provider for healthcare professionals, to enhance its digital training strategy and expand its service offerings in the healthcare sector [2][4][6]. Company Overview - Equasens is a prominent provider of digital solutions for healthcare professionals, employing over 1,400 people across Europe and focusing on software, hardware, financing, and data-hosting solutions [14]. - Erevo, founded in 2018, specializes in online education for healthcare professionals, offering over 80 e-learning courses and serving a community of more than 20,000 trained learners [3][11]. Acquisition Details - The acquisition of Erevo is expected to generate revenue of €7.4 million in 2025, aligning with Equasens' profitable growth strategy [4]. - The transaction was funded through bank financing and includes a call option on the remaining 20% stake, with the option value linked to Erevo's future performance [9]. Strategic Synergies - The acquisition is anticipated to create significant operational, marketing, and sales synergies between Equasens' existing training offerings and Erevo's programs [7]. - Erevo's innovative training model, which includes virtual classrooms and a comprehensive support system, complements Equasens' existing services and enhances its digital training portfolio [5][6]. Market Positioning - Erevo is recognized for its high-quality training programs, which are eligible for funding under French professional education schemes, making it a leading provider in the continuing education market for healthcare professionals [5][11]. - The acquisition aligns with Equasens' strategy to support healthcare professionals in both primary care and hospital settings, thereby broadening its market reach [6][8].

Group 1 - WELL Health Technologies is a serial acquirer in the digital health market, experiencing rapid growth with a strong acquisition pipeline and macro tailwinds that position it for continued success in 2026 [1] Group 2 - The company has a beneficial long position in its shares, indicating confidence in its future performance [2] - The article expresses the author's own opinions and is not influenced by any business relationships with companies mentioned [2]

VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”), a digital health platform enabling on-demand care, pharmacy fulfillment, and enterprise healthcare services across the United States, today announced its entry into the rapidly expanding at-home sexually transmitted infection (“STI”) pre-screening market through an exclusive distribution agreement with Health Screen Collective (“HSC”). Under the agreement, Hydreight will serve as the ex ...